Maital Shemesh Rasmussen is Director of PLURISTEM THERAPEUTICS INC. Currently has a direct ownership of 19,144 shares of PSTI, which is worth approximately $13,400. The most recent transaction as insider was on Dec 04, 2025, when has been sold 699 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 19.1K
3.79% 3M change
67.08% 12M change
Total Value Held $13,400

Maital Shemesh-Rasmussen Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 04 2025
BUY
Grant, award, or other acquisition
-
699 Added 3.52%
19,144 Common Stock
Feb 25 2025
BUY
Grant, award, or other acquisition
-
11,173 Added 37.72%
18,445 Common Stock
Jan 23 2024
BUY
Grant, award, or other acquisition
-
38,150 Added 39.62%
58,150 Common Stock
Jan 05 2021
BUY
Grant, award, or other acquisition
-
20,000 Added 50.0%
20,000 Restricted Stock Units
MS

Maital Shemesh Rasmussen

Director
Haifa, L3

Track Institutional and Insider Activities on PSTI

Follow PLURISTEM THERAPEUTICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PSTI shares.

Notify only if

Insider Trading

Get notified when an Pluristem Therapeutics Inc insider buys or sells PSTI shares.

Notify only if

News

Receive news related to PLURISTEM THERAPEUTICS INC

Track Activities on PSTI